Sepsis Diagnostics Market to Surpass USD 1.2 Billion by 2033, Driven by an 8.1% CAGR

The global sepsis diagnostics market is set to experience substantial growth over the next decade, with an anticipated compound annual growth rate (CAGR) of 8.1% from 2023 to 2033. Valued at USD 561.2 million in 2023, the market is projected to more than double, reaching over USD 1.2 billion by 2033. This growth underscores the increasing importance of rapid and accurate diagnostic solutions in combating sepsis, a critical and life-threatening condition.

Sepsis remains a major global health concern, affecting millions of patients annually. The rise in prevalence of sepsis, coupled with advancements in diagnostic technologies, is driving market expansion. Early detection through innovative diagnostics can significantly improve patient outcomes, reduce mortality rates, and lower healthcare costs, making these tools indispensable in modern medicine.

The market growth is further fueled by heightened awareness among healthcare providers and governments regarding the benefits of early sepsis diagnosis. Technological advancements such as molecular diagnostics, biomarker-based assays, and point-of-care testing are revolutionizing the field. Key market players are focused on enhancing their offerings to meet the demand for faster, more accurate, and cost-effective sepsis diagnostic solutions.

Key Takeaways:

• The global sepsis diagnostics market is expected to grow from USD 561.2 million in 2023 to over USD 1.2 billion by 2033, at a CAGR of 8.1%.
• Increasing sepsis prevalence and the critical need for early detection are key market drivers.
• Technological innovations, including molecular diagnostics and biomarker-based assays, are reshaping the market landscape.
• Enhanced awareness and governmental initiatives are contributing to the adoption of advanced sepsis diagnostic tools.

Request a Sample of this Report Now: https://www.futuremarketinsights.com/reports/sample/rep-gb-14272
Factors that are expected to drive the market growth are:

• The surge in the number of people suffering from the flu
• Increasing Hospital Acquired Infections
• Surging geriatric population that suffers from chronic diseases

During the COVID-19 pandemic, there was an increase in people who were getting hospitalized. This led to a surge in the cases of sepsis as well. Thus, an increasing prevalence of hospital-borne diseases, along with the prevalence of chronic diseases across age groups, might surge the growth of the market.

Research & Development Investment to Drive the Market Growth

The global sepsis diagnostics market is expected to grow due to increased research and development efforts. Using a microelectrode biosensor, the sepsis diagnostic devices identify interleukin-6, a protein biomarker, in less than three minutes.

Hospital-acquired infections (HAIs), also known as nosocomial infections, are a leading source of morbidity and death around the world. Urinary tract infections, pneumonia, and sepsis are the most frequent hospital-acquired infections.

Sepsis molecular diagnostics among hospitalized patients in the United States has been increasing at an annual rate of 8.7%. With the significant growth of HAIs throughout the world, the market for sepsis diagnostic devices is projected to surge in the future years.

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube